These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19552484)

  • 1. Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders.
    Curia G; Biagini G; Perucca E; Avoli M
    CNS Drugs; 2009; 23(7):555-68. PubMed ID: 19552484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
    Errington AC; Stöhr T; Heers C; Lees G
    Mol Pharmacol; 2008 Jan; 73(1):157-69. PubMed ID: 17940193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na
    Holtkamp D; Opitz T; Niespodziany I; Wolff C; Beck H
    Epilepsia; 2017 Jan; 58(1):27-41. PubMed ID: 27864845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.
    Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J
    CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation.
    Niespodziany I; Leclère N; Vandenplas C; Foerch P; Wolff C
    J Neurosci Res; 2013 Mar; 91(3):436-43. PubMed ID: 23239147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.
    Becerra JL; Ojeda J; Corredera E; Ruiz Giménez J
    CNS Drugs; 2011 Dec; 25 Suppl 1():3-16. PubMed ID: 22141347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lacosamide. A new antiepileptic drug as adjunctive therapy in patients with partial-onset seizures].
    Saussele T
    Med Monatsschr Pharm; 2008 Oct; 31(10):374-7. PubMed ID: 18972867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States.
    Jo S; Bean BP
    Mol Pharmacol; 2017 Apr; 91(4):277-286. PubMed ID: 28119481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current understanding of the mechanism of action of the antiepileptic drug lacosamide.
    Rogawski MA; Tofighy A; White HS; Matagne A; Wolff C
    Epilepsy Res; 2015 Feb; 110():189-205. PubMed ID: 25616473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.
    Beydoun A; D'Souza J; Hebert D; Doty P
    Expert Rev Neurother; 2009 Jan; 9(1):33-42. PubMed ID: 19102666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel medications for epilepsy.
    Fattore C; Perucca E
    Drugs; 2011 Nov; 71(16):2151-78. PubMed ID: 22035515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voltage-gated sodium channels: pharmaceutical targets via anticonvulsants to treat epileptic syndromes.
    Abdelsayed M; Sokolov S
    Channels (Austin); 2013; 7(3):146-52. PubMed ID: 23531742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating sodium channel slow inactivation.
    Wang Y; Brittain JM; Jarecki BW; Park KD; Wilson SM; Wang B; Hale R; Meroueh SO; Cummins TR; Khanna R
    J Biol Chem; 2010 Aug; 285(33):25296-307. PubMed ID: 20538611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of epilepsy: newly approved and developmental agents.
    Stephen LJ; Brodie MJ
    CNS Drugs; 2011 Feb; 25(2):89-107. PubMed ID: 21254787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacosamide, a newer antiepileptic.
    Patyar S; Medhi B
    Neurosciences (Riyadh); 2010 Jan; 15(1):3-6. PubMed ID: 20677583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arbidol, an antiviral drug, identified as a sodium channel blocker with anticonvulsant activity.
    Li M; Jin Y; Wu J; Zhao M; Yu K; Yu H
    Br J Pharmacol; 2024 Nov; 181(21):4311-4327. PubMed ID: 38982721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacosamide for the treatment of epilepsy.
    Krauss GL; Edwards HB; Lin B
    Ann Med; 2012 Nov; 44(7):674-9. PubMed ID: 22380697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
    Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
    Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic ineffectiveness of lacosamide after spinal nerve ligation and its sodium channel activity in injured neurons.
    Hagenacker T; Schäfer N; Büsselberg D; Schäfers M
    Eur J Pain; 2013 Jul; 17(6):881-92. PubMed ID: 23229998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lacosamide and carbamazepine on human motor cortex excitability: a double-blind, placebo-controlled transcranial magnetic stimulation study.
    Lang N; Rothkegel H; Peckolt H; Deuschl G
    Seizure; 2013 Nov; 22(9):726-30. PubMed ID: 23778157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.